Search Within

Martin Stuart Tallman

Formats
  1. Journal Article (320)
  2. Meeting Abstract (278)
  3. Review (19)
  4. Editorial (9)
  5. Book Section (8)
  6. Research Letter (8)
  7. Guidelines (6)
  8. Correspondence (1)
Groups
  1. Adult Leukemia (649)
  2. Center for Hematologic Malignancies (649)
  3. Department of Medicine (649)
  4. Hematologic Malignancies, Division of (649)
  5. GSK Faculty (164)
  6. Executive Committee, Center for Hematologic Malignancies (156)

More Groups

People
  1. Ross Levine (131)
  2. Eytan Stein (114)
  3. Jae Park (79)
  4. Omar Abdel-Wahab (68)
  5. Sean Devlin (65)
  6. Dan Douer (50)

More People

Years
  1. 2025 (3)
  2. 2024 (7)
  3. 2023 (10)
  4. 2022 (26)
  5. 2021 (45)
  6. 2020 (51)

More Years

Publications
  1. Blood (272)
  2. Journal of Clinical Oncology (41)
  3. Leukemia Research (27)
  4. Blood Advances (26)
  5. Leukemia and Lymphoma (26)
  6. Haematologica (24)

More Publications

Publishers
  1. American Society of Hematology (298)
  2. Elsevier Inc. (43)
  3. American Society of Clinical Oncology (41)
  4. Nature Publishing Group (38)
  5. Taylor & Francis Group (28)
  6. Elsevier Ltd (27)

More Publishers

Results (649)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Persistent Problems with Persistent Disease: Minimal Residual Disease in Acute Myelogeous Leukemia
    Journal Article

    Stein, E. M.; Tallman, M. S.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis
    Journal Article

    Diab, A.; Zickl, L.; Abdel-Wahab, O.; Jhanwar, S.; Gulam, M. A.; Panageas, K. S.; Patel, J. P.; Jurcic, J.; Maslak, P.; Paietta, E.; more...
    Leukemia Research (2013)

    Fulltext@MSK | Save
  • Outcomes of patients older than 60 years with acute lymphoblastic leukemia: Survey from the Surveillance, Epidemiology, and End Results (SEER) program
    Meeting Abstract

    Park, J. H.; Devlin, S.; Tallman, M. S.; Douer, D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A comparison of CR versus CRi response following CPX-351 treatment of newly diagnosed AML in elderly patients (pts)
    Meeting Abstract

    Lancet, J. E.; Cortes, J. E.; Kovacsovics, T.; Hogge, D.; Kolitz, J. E.; Tallman, M. S.; Chiarella, M.; Louie, A. C.; Feldman, E. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Practically all patients with acute myeloid leukemia (AML) in continuous complete remission for 3 years or more are cured of their disease: The ECOG experience
    Meeting Abstract

    Watts, J. M.; Zickl, L.; Litzow, M. R.; Luger, S. M.; Lazarus, H. M.; Cassileth, P. A.; Fernandez, H. F.; Douer, D.; Paietta, E.; Rowe, J. M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Acute leukemias following a diagnosis of colorectal cancer: Are they therapy-related?
    Meeting Abstract

    Stein, E. M.; Pareek, V.; Kudlowitz, D.; Douer, D.; Tallman, M. S.
    Blood (2012)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in patients with acute myeloid leukemia (AML) in complete remission (CR)
    Meeting Abstract

    Rosenblat, T. L.; Frattini, M. G.; Chanel, S. M.; Dao, T.; Bernal, Y.; Jurcic, J. G.; Zhang, R.; Simancek, P.; Tallman, M. S.; Scheinberg, D. A.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Aberrant expression of the MLL5, BAALC, ID1, and WT1 genes is associated with higher induction mortality and poorer overall survival in acute promyelocytic leukemia patients treated with ATRA and anthracycline-based chemotherapy: An international consortium on acute promyelocytic leukemia study
    Meeting Abstract

    Lucena-Araujo, A. R.; Jacomo, R. H.; Kim, H. T.; Melo, R. A.; Bittencourt, R.; Pasquini, R.; Pagnano, K. B.; Fagundes, E.; Chauffaille, Mdlf; Chiattone, C. S.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Clonal chromosomal anomalies similar to CLL and other hematologic malignancies can be found in "normal" individuals
    Meeting Abstract

    Laurie, C. C.; Laurie, C. A.; Fridley, B.; Carlson, E.; Smoley, S. A.; Flinn, I. W.; Tallman, M. S.; Paietta, E.; Weinshilboum, R.; Kay, N. E.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • CPX-351 is effective in newly diagnosed older patients with AML and with multiple risk factors
    Meeting Abstract

    Lancet, J. E.; Cortes, J. E.; Kovacsovics, T.; Hogge, D. E.; Kolitz, J. E.; Tallman, M. S.; Hoering, A.; Chiarella, M. T.; Louie, A. C.; Feldman, E.
    Blood (2012)

    Fulltext@MSK | Save